Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Germany · Delayed Price · Currency is EUR

0.855

+0.015 (1.79%)

At close: Dec 5, 2025

-29.92% (1Y)

Market Cap	851.86M
Revenue (ttm)	845.22M
Net Income (ttm)	79.69M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	10.69
Forward PE	8.05
Dividend	0.04 (4.38%)
Ex-Dividend Date	Sep 18, 2025

Volume	n/a
Average Volume	n/a
Open	0.855
Previous Close	0.840
Day's Range	0.855 - 0.855
52-Week Range	0.770 - 1.350
Beta	n/a
RSI	58.56
Earnings Date	Feb 26, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta... [Read more]

Industry Pharmaceutical Preparations

Founded 1996

Employees 1,665

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol GEKA

Full Company Profile

Financial Performance

In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.

Financial numbers in MXN Financial Statements

News

There is no news available yet.